Article Summary
赵莉芳 郑宏超 缪培智 徐亚伟 顾水明.ACE、 CYP1 1B2 基因多态性与慢性心力衰竭患者醛固酮脱逸的关系[J].现代生物医学进展英文版,2015,15(5):900-904.
ACE、 CYP1 1B2 基因多态性与慢性心力衰竭患者醛固酮脱逸的关系
The Relationship between ACE, CYP11 B2 Gene Polymorphism and Escapeof Aldosterone in Patients with Chronic Heart Failure
  
DOI:
中文关键词: 醛固 酮脱逸  慢性心力衰竭  基因 多 态性  CYP11 B2  ACE
英文关键词: Aldosterone escape  Chronic heart failure  Gene polymorphism  CYP11 B2  ACE
基金项目:上海市科技局基金项目( SHXH2011 39)
Author NameAffiliation
赵莉芳 郑宏超 缪培智 徐亚伟 顾水明 上海徐汇区中心医院心内科 
Hits: 836
Download times: 1178
中文摘要:
      目的: 研究 CYP11 B2-344C/T(醛固酮合成酶)及 ACEI/D(血管紧张素转化酶)基因 多 态性与慢性心力衰竭(CHF)患者实施 ACEI 治疗后出现醛固酮脱逸表现的关系。 方法: 回顾分析 2008 年 10 月 至 2012 年 10 月 我科收治的 252 例 CHF 患者, 全部患者应用 ACEI 治疗 3 月 ,醛固酮在基线以上为醛固 酮脱逸,依据此标准将患者分为研究组(脱逸组, n=86)与对照组(非脱逸组, n=1 66),依据 PCR(聚合酶链反应)及 RFLP(片 段长度限制多 态性)等方法分别检测两组 CYP11 B2 及 ACE 基因型, 比较两组基因型频率的分布。 结果: 252 例 患者中, 共 86 例 出现醛固酮脱逸, 发生率为 34.1%。 全部受试患者 CYP11 B2 基因型及 ACE 基因型频率与 Weinberg-Hardy 平衡均相符(P 均 >0.05)。 研究组 ACE I/D 三种基因型的组间分布与对照组相较, 无统计学差异(P>0.05); CYP1 1B2 基 因 TT 型的频率与对照组相较,呈明 显统计学差异(P<0.05), 等位基因 C/T 频率的组间分布同 对照组相较, 亦呈明显差异(P<0.05)。 研究组 ACEI/D 的基因 多 态性及 CYP11 B2-344C/T 的多 态性中,基因型联合组间 分布与对照组相较, 无统计学差异(P>0.05)。 结 论: ACE 基因 多 态性与 CHF 患者 ACEI 治疗后出 现醛固酮脱逸无关, CYP11 B2 基因 T 等位基因 及 TT 基因型多 态性可能是 CHF 患者 ACEI 治疗后发生醛固酮脱逸的高危因素。 醛固酮脱逸时, ACE、CYP1 1B2 基因 不具有协同 效果。
英文摘要:
      Objective:To study the relationship between CYP11 B2-344-c/T(aldosterone synthase) and ACEI/D(angiotensin converting enzyme gene polymorphism and patients with chronic heart failure (CHF) after the implementation of ACEI treatment aldosterone extruding performance.Methods:252 patients with CHF admitted in our department from October 2008 to October 201 2 were, retrospectively, analyzed. All the patients were treated by ACEI for 3 months. Aldosterone above baseline was considered as aldosterone escape, patients were divided into research group (extruding group, n=86) and control group (non-extruding group, n=166) according to this standard, PCR (polymerase chain reaction) and RFLP (fragment length polymorphism) method were used to detect and compare the CYP11 B2 and ACE genotype distribution.Results:In 252 cases of patients, a total of 86 cases (34.1 %) with aldosterone extruding were observed, All the patients' CYP1 1B2 gene type and ACE genotype frequency and Weinberg-Hardy balance were consistent (P>0.05). No significant difference was found in the three ACE I/D genotype distribution between research group and control group (P>0.05); the TT frequency of CYP1 1B2 genotype, allele C/T frequency distribution of research group were significantly different from that of the control group(P<0.05). No statistical difference was observed in the team of ACEI/D gene polymorphism and CYP11 B2-344-c/T polymorphism, genotype distribution between the joint groups compared with control group (P>0.05).Conclusion:ACE gene polymorphism had no correlation with the aldosterone escape after ACEI treatment of CHF patients, T allele and genotype TT of CYP11 B2 gene polymorphisms may be risk factors of aldosterone escape after ACEI treatment, ACE, CYP1 1B2 gene hadn't synergistic effect during the aldosterone escape.
View Full Text   View/Add Comment  Download reader
Close